Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study
- PMID: 33323270
- DOI: 10.1016/S2589-7500(19)30105-0
Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study
Abstract
Background: Development of valid, non-invasive biomarkers for parkinsonian syndromes is crucially needed. We aimed to assess whether non-invasive diffusion-weighted MRI can distinguish between parkinsonian syndromes using an automated imaging approach.
Methods: We did an international study at 17 MRI centres in Austria, Germany, and the USA. We used diffusion-weighted MRI from 1002 patients and the Movement Disorders Society Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS III) to develop and validate disease-specific machine learning comparisons using 60 template regions and tracts of interest in Montreal Neurological Institute space between Parkinson's disease and atypical parkinsonism (multiple system atrophy and progressive supranuclear palsy) and between multiple system atrophy and progressive supranuclear palsy. For each comparison, models were developed on a training and validation cohort and evaluated in an independent test cohort by quantifying the area under the curve (AUC) of receiving operating characteristic curves. The primary outcomes were free water and free-water-corrected fractional anisotropy across 60 different template regions.
Findings: In the test cohort for disease-specific comparisons, the diffusion-weighted MRI plus MDS-UPDRS III model (Parkinson's disease vs atypical parkinsonism had an AUC 0·962; multiple system atrophy vs progressive supranuclear palsy AUC 0·897) and diffusion-weighted MRI only model had high AUCs (Parkinson's disease vs atypical parkinsonism AUC 0·955; multiple system atrophy vs progressive supranuclear palsy AUC 0·926), whereas the MDS-UPDRS III only models had significantly lower AUCs (Parkinson's disease vs atypical parkinsonism 0·775; multiple system atrophy vs progressive supranuclear palsy 0·582). These results indicate that a non-invasive imaging approach is capable of differentiating forms of parkinsonism comparable to current gold standard methods.
Interpretations: This study provides an objective, validated, and generalisable imaging approach to distinguish different forms of parkinsonian syndromes using multisite diffusion-weighted MRI cohorts. The diffusion-weighted MRI method does not involve radioactive tracers, is completely automated, and can be collected in less than 12 min across 3T scanners worldwide. The use of this test could positively affect the clinical care of patients with Parkinson's disease and parkinsonism and reduce the number of misdiagnosed cases in clinical trials.
Funding: National Institutes of Health and Parkinson's Foundation.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Comment in
-
Improving parkinsonism diagnosis with machine learning.Lancet Digit Health. 2019 Sep;1(5):e196-e197. doi: 10.1016/S2589-7500(19)30107-4. Epub 2019 Aug 27. Lancet Digit Health. 2019. PMID: 33323265 No abstract available.
Similar articles
-
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.Lancet Digit Health. 2019 Sep;1(5):e222-e231. doi: 10.1016/s2589-7500(19)30105-0. Epub 2019 Aug 27. Lancet Digit Health. 2019. PMID: 32259098 Free PMC article.
-
Free-water imaging in Parkinson's disease and atypical parkinsonism.Brain. 2016 Feb;139(Pt 2):495-508. doi: 10.1093/brain/awv361. Epub 2015 Dec 24. Brain. 2016. PMID: 26705348 Free PMC article.
-
Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects.Eur J Radiol. 2014 Nov;83(11):2074-9. doi: 10.1016/j.ejrad.2014.07.012. Epub 2014 Jul 24. Eur J Radiol. 2014. PMID: 25154005
-
[Differential diagnosis of parkinsonian syndromes using MRI].Nervenarzt. 2010 Oct;81(10):1168-79. doi: 10.1007/s00115-010-3022-8. Nervenarzt. 2010. PMID: 20857276 Review. German.
-
MRI Signs of Parkinson's Disease and Atypical Parkinsonism.Rofo. 2021 Dec;193(12):1403-1410. doi: 10.1055/a-1460-8795. Epub 2021 May 25. Rofo. 2021. PMID: 34034347 Review. English, German.
Cited by
-
The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism.Front Neurol. 2020 Jul 17;11:665. doi: 10.3389/fneur.2020.00665. eCollection 2020. Front Neurol. 2020. PMID: 32765399 Free PMC article. Review.
-
NANOTECHNOLOGY-MEDIATED THERAPEUTIC STRATEGIES AGAINST SYNUCLEINOPATHIES IN NEURODEGENERATIVE DISEASE.Curr Opin Chem Eng. 2021 Mar;31:100673. doi: 10.1016/j.coche.2021.100673. Epub 2021 Feb 5. Curr Opin Chem Eng. 2021. PMID: 35419254 Free PMC article.
-
Hybrid CNN-LSTM model with efficient hyperparameter tuning for prediction of Parkinson's disease.Sci Rep. 2023 Sep 5;13(1):14605. doi: 10.1038/s41598-023-41314-y. Sci Rep. 2023. Retraction in: Sci Rep. 2024 Nov 7;14(1):27077. doi: 10.1038/s41598-024-78418-y. PMID: 37669970 Free PMC article. Retracted.
-
α-Synuclein Induces Progressive Changes in Brain Microstructure and Sensory-Evoked Brain Function That Precedes Locomotor Decline.J Neurosci. 2020 Aug 19;40(34):6649-6659. doi: 10.1523/JNEUROSCI.0189-20.2020. Epub 2020 Jul 15. J Neurosci. 2020. PMID: 32669353 Free PMC article.
-
White matter microstructural metrics are sensitively associated with clinical staging in Alzheimer's disease.Alzheimers Dement (Amst). 2023 May 17;15(2):e12425. doi: 10.1002/dad2.12425. eCollection 2023 Apr-Jun. Alzheimers Dement (Amst). 2023. PMID: 37213219 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous